HCA

SEC source: 0001209191-20-057213 · doc4.xml · derivative · entry 12

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,500 shares

Expires 2023-02-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014.

SEC source: 0001209191-20-057213 · doc4.xml · derivative · entry 11

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2022-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets.

SEC source: 0001209191-20-057213 · doc4.xml · derivative · entry 10

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2022-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013.

SEC source: 0001209191-20-057213 · doc4.xml · nonDerivative · entry 3

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,659

SEC source: 0001209191-20-057213 · doc4.xml · nonDerivative · entry 2

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,720

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-057213 · doc4.xml · nonDerivative · entry 1

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,145

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-056993 · doc4.xml · nonDerivative · entry 1

Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,597.8654

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.575 to $127.88, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-20-058188 · doc4.xml · nonDerivative · entry 1

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,053

SEC source: 0001209191-20-056466 · doc4.xml · nonDerivative · entry 1

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,964

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.40 to $124.42, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-20-056264 · doc4.xml · nonDerivative · entry 1

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,771

SEC source: 0001209191-20-056263 · doc4.xml · derivative · entry 17

Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,525 shares

Expires 2024-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.

SEC source: 0001209191-20-056263 · doc4.xml · derivative · entry 16

Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,500 shares

Expires 2024-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015.

SEC source: 0001209191-20-056263 · doc4.xml · derivative · entry 15

Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,375 shares

Expires 2023-02-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets.

SEC source: 0001209191-20-056263 · doc4.xml · derivative · entry 14

Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,250 shares

Expires 2023-02-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014.

SEC source: 0001209191-20-056263 · doc4.xml · nonDerivative · entry 13

Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust (Spouse, Trustee)

Disclosed balance after: 1,764

SEC source: 0001209191-20-056263 · doc4.xml · nonDerivative · entry 12

Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer

10b5-1 filing: Not disclosed

Ownership: Indirect · By LM 2020 GRAT

Disclosed balance after: 4,862

SEC source: 0001209191-20-056263 · doc4.xml · nonDerivative · entry 11

Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer

10b5-1 filing: Not disclosed

Ownership: Indirect · By JM 2020 GRAT

Disclosed balance after: 4,863

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.7046 to $134.7218, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-20-056263 · doc4.xml · nonDerivative · entry 10

Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,576.2235

F1 · balance_after: Includes 1,358.2235 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-20-056263 · doc4.xml · nonDerivative · entry 9

Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,008.2235

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 1,358.2235 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-20-056263 · doc4.xml · nonDerivative · entry 8

Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,983.2235

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 1,358.2235 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-21-010862 · doc5.xml · nonDerivative · entry 1

Frist William R · CIK 0001433377 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly through Hercules Holding II by the William R. Frist August 2020 GRAT

Disclosed balance after: 941,764.95

F1 · ownership.nature: The Reporting Person received a gift of 9,507.582951 units of Hercules Holding II ("Hercules") on August 12, 2020, which were subsequently transferred to the William R. Frist August 2020 GRAT, of which he serves as trustee. Following receipt of this gift, the Reporting Person may be deemed to be the beneficial owner of the units of Hercules held by this trust and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

F2 · ownership.nature: Hercules holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.

SEC source: 0001209191-21-010858 · doc5.xml · nonDerivative · entry 1

FRIST PATRICIA C · CIK 0001181963 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly through Hercules Holding II by Patricia Champion Frist May 2018 GRAT

Disclosed balance after: 0

F1 · ownership.nature: The Reporting Person's spouse is trustee of (i) the Thomas F. Frist GST Tax Exempt Trust, (ii) the Patricia Champion Frist May 2019 Grantor Retained Annuity Trust, (iii) the Patricia Champion Frist August 2019 Grantor Retained Annuity Trust, (iv) the Patricia Champion Frist 2020 Grantor Retained Annuity Trust and (v) the Patricia Champion Frist May 2018 Grantor Retained Annuity Trust and may be deemed to be the beneficial owner of the units of Hercules Holding II ("Hercules") held by these trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

F2 · ownership.nature: Hercules holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

SEC source: 0001209191-21-010856 · doc5.xml · nonDerivative · entry 1

FRIST THOMAS F JR · CIK 0000900596 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly through Hercules Holding II by Patricia Champion Frist May 2018 GRAT

Disclosed balance after: 0

F1 · ownership.nature: The Reporting Person is trustee of (i) the Thomas F. Frist GST Tax Exempt Trust, (ii) the Patricia Champion Frist May 2019 Grantor Retained Annuity Trust, (iii) the Patricia Champion Frist August 2019 Grantor Retained Annuity Trust, (iv) the Patricia Champion Frist 2020 Grantor Retained Annuity Trust and (v) the Patricia Champion Frist May 2018 Grantor Retained Annuity Trust and may be deemed to be the beneficial owner of the units of Hercules Holding II ("Hercules") held by these trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

F2 · ownership.nature: Hercules holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.

SEC source: 0001209191-21-010854 · doc5.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly through Hercules Holding II

Disclosed balance after: 9,507.583

F1 · ownership.nature: The Reporting Person directly owns 9,507.58295 units of Hercules Holding II ("Hercules") and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

F2 · ownership.nature: Hercules holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.

SEC source: 0001209191-21-010853 · doc5.xml · nonDerivative · entry 10

Elcan Patricia F · CIK 0001433376 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly by GRATs

Disclosed balance after: 7,676,826.2551

F2 · ownership.nature: Hercules holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

F4 · ownership.nature: The Reporting Person is trustee of three grantor retained annuity trusts for the benefit of her children, and the Reporting Person's spouse is trustee of three grantor retained annuity trusts for the benefit of the Reporting Person's children. The Reporting Person may, accordingly, be deemed to be the beneficial owner of the aggregate 116,766 shares of common stock of HCA Healthcare, Inc. held by such trusts. In addition, the Reporting Person may be deemed to be the beneficial owner of the 7,560,060.255067 units of Hercules held by such trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

SEC source: 0001209191-21-010853 · doc5.xml · nonDerivative · entry 9

Elcan Patricia F · CIK 0001433376 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly through Hercules Holding II by Patricia F. Elcan 2018 Annuity Trust II

Disclosed balance after: 0

F2 · ownership.nature: Hercules holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

F6 · ownership.nature: The Reporting Person is trustee of the Patricia F. Elcan 2018 Annuity Trust II and the Reporting Person may therefore be deemed to be the beneficial owner of the units of Hercules held by such trust and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

SEC source: 0001209191-21-010853 · doc5.xml · nonDerivative · entry 8

Elcan Patricia F · CIK 0001433376 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly through Hercules Holding II

Disclosed balance after: 561,642.9696

F2 · ownership.nature: Hercules holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

F5 · ownership.nature: The Reporting Person directly owns 561,642.969626 units of Hercules and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. by virtue of her ownership in Hercules.

SEC source: 0001209191-20-046665 · doc4.xml · derivative · entry 11

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,300

Underlying: Common Stock · 18,300 shares

Expires 2028-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019.

SEC source: 0001209191-20-046665 · doc4.xml · derivative · entry 10

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,878

Underlying: Common Stock · 20,632 shares

Expires 2027-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018.

SEC source: 0001209191-20-046665 · doc4.xml · derivative · entry 9

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,910 shares

Expires 2026-01-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017.

SEC source: 0001209191-20-046665 · doc4.xml · derivative · entry 8

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,000 shares

Expires 2025-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016.

SEC source: 0001209191-20-046665 · doc4.xml · nonDerivative · entry 6

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 230,203

SEC source: 0001209191-20-046665 · doc4.xml · nonDerivative · entry 5

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 230,961

SEC source: 0001209191-20-046665 · doc4.xml · nonDerivative · entry 4

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 282,534

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-046665 · doc4.xml · nonDerivative · entry 3

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 264,234

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-046665 · doc4.xml · nonDerivative · entry 2

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 243,602

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-046665 · doc4.xml · nonDerivative · entry 1

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 219,692

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-046667 · doc4.xml · nonDerivative · entry 1

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,621

SEC source: 0001209191-20-046666 · doc4.xml · nonDerivative · entry 7

MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,626

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.60 to $133.89, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-20-046664 · doc4.xml · nonDerivative · entry 1

Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,744

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.52 to $132.96, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-20-046014 · doc4.xml · nonDerivative · entry 2

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,848

SEC source: 0001209191-20-057537 · doc4.xml · nonDerivative · entry 6

Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO

10b5-1 filing: Not disclosed

Ownership: Indirect · By DJP 2020 Trust

Disclosed balance after: 50,000

SEC source: 0001209191-20-057537 · doc4.xml · nonDerivative · entry 5

Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 0

SEC source: 0001209191-20-046014 · doc4.xml · nonDerivative · entry 1

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,442

SEC source: 0001209191-20-056263 · doc4.xml · nonDerivative · entry 7

Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer

10b5-1 filing: Not disclosed

Ownership: Indirect · By JM 2020 GRAT

Disclosed balance after: 6,478

SEC source: 0001209191-20-056263 · doc4.xml · nonDerivative · entry 6

Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,358.2235

F1 · balance_after: Includes 1,358.2235 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-21-010853 · doc5.xml · nonDerivative · entry 7

Elcan Patricia F · CIK 0001433376 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly by GRATs

Disclosed balance after: 5,736,048.0365

F2 · ownership.nature: Hercules holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

F4 · ownership.nature: The Reporting Person is trustee of three grantor retained annuity trusts for the benefit of her children, and the Reporting Person's spouse is trustee of three grantor retained annuity trusts for the benefit of the Reporting Person's children. The Reporting Person may, accordingly, be deemed to be the beneficial owner of the aggregate 116,766 shares of common stock of HCA Healthcare, Inc. held by such trusts. In addition, the Reporting Person may be deemed to be the beneficial owner of the 7,560,060.255067 units of Hercules held by such trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

SEC source: 0001209191-21-010853 · doc5.xml · nonDerivative · entry 6

Elcan Patricia F · CIK 0001433376 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly through Hercules Holding II

Disclosed balance after: 552,135.3867

F2 · ownership.nature: Hercules holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

F5 · ownership.nature: The Reporting Person directly owns 561,642.969626 units of Hercules and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. by virtue of her ownership in Hercules.

SEC source: 0001209191-20-056263 · doc4.xml · nonDerivative · entry 5

Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer

10b5-1 filing: Not disclosed

Ownership: Indirect · By LM 2020 GRAT

Disclosed balance after: 6,487

SEC source: 0001209191-20-056263 · doc4.xml · nonDerivative · entry 4

Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 0